What is Sidoti Csr’s Forecast for USNA Q1 Earnings?

USANA Health Sciences, Inc. (NYSE:USNA) – Equities research analysts at Sidoti Csr increased their Q1 2025 earnings per share (EPS) estimates for shares of USANA Health Sciences in a research note issued to investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post earnings per share of $0.84 for the quarter, up from their prior forecast of $0.73. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

USNA has been the subject of several other reports. DA Davidson raised shares of USANA Health Sciences to a “hold” rating in a research note on Friday, December 20th. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday.

USANA Health Sciences Trading Down 0.7 %

Shares of USNA stock opened at $35.69 on Friday. The firm has a fifty day moving average price of $37.88 and a 200 day moving average price of $39.94. The company has a market cap of $680.25 million, a P/E ratio of 12.61, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a 12 month low of $31.44 and a 12 month high of $54.81.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter in the previous year, the firm earned $0.59 earnings per share.

Insider Activity

In other news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Institutional Trading of USANA Health Sciences

Institutional investors and hedge funds have recently bought and sold shares of the business. Pzena Investment Management LLC grew its stake in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after buying an additional 72,977 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of USANA Health Sciences by 0.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock valued at $30,907,000 after acquiring an additional 3,889 shares in the last quarter. Pacer Advisors Inc. boosted its position in USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares during the period. State Street Corp increased its holdings in USANA Health Sciences by 0.6% in the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after purchasing an additional 2,782 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after purchasing an additional 12,898 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.